The Oncology Institute, Inc. TOI Fair Value Adjustment Of Warrants
Fair Value Adjustment Of Warrants at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s fair value adjustment of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s fair value adjustment of warrants?
- The Oncology Institute, Inc. (TOI) reported fair value adjustment of warrants of -$168K in Q1 2026.
- How has The Oncology Institute, Inc.'s fair value adjustment of warrants changed year-over-year?
- The Oncology Institute, Inc.'s fair value adjustment of warrants decreased by 490.7% year-over-year, from $43K to -$168K.
- What is the long-term trend for The Oncology Institute, Inc.'s fair value adjustment of warrants?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s fair value adjustment of warrants has grown at a -49.1% compound annual growth rate (CAGR), from -$3.69M to $247K.
- What does fair value adjustment of warrants mean?
- Reflects the non-cash gain or loss resulting from the periodic revaluation of liability-classified warrants at fair value. Changes in this metric are driven by fluctuations in the company's stock price and volatility, impacting reported net income without affecting cash flow.